Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 190 Records) |
| Query Trace: Lymphoma and IMPACT[original query] |
|---|
| Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 12 40 (4): 369-381. Shouval Roni, Alarcon Tomas Ana, Fein Joshua A, Flynn Jessica R, Markovits Ettai, Mayer Shimrit, Olaide Afuye Aishat, Alperovich Anna, Anagnostou Theodora, Besser Michal J, Batlevi Connie Lee, Dahi Parastoo B, Devlin Sean M, Fingrut Warren B, Giralt Sergio A, Lin Richard J, Markel Gal, Salles Gilles, Sauter Craig S, Scordo Michael, Shah Gunjan L, Shah Nishi, Scherz-Shouval Ruth, van den Brink Marcel, Perales Miguel-Angel, Palomba Maria L |
| High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C?>?T rs1045642 and MTHFR 677C?>?T rs1801133 polymorphisms on toxicities and delayed elimination. Journal of chemotherapy (Florence, Italy) 2021 12 34 (6): 381-390. Ebid Abdel-Hameed I M, Hossam Ahmed, El Gammal Mosaad M, Soror Sameh, Mangoud Nadia O M, Mahmoud Mohamed Ad |
| The Influence of Interleukin-2 Gene Polymorphisms on the Risk and Clinical Outcome of Non-Hodgkin Lymphoma. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2021 11 37 (4): 549-554. Mousa Somaia Mohammed, Makhlouf Manal Mohamed, Mohammed Ekhlass Talaat, Zawam Hamdy Moham |
| Influence of TP53 Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era. Cancers 2021 11 13 (22): . Porpaczy Edit, Wohlfarth Philipp, Königsbrügge Oliver, Rabitsch Werner, Skrabs Cathrin, Staber Philipp, Worel Nina, Müllauer Leonhard, Simonitsch-Klupp Ingrid, Kornauth Christoph, Rohrbeck Johannes, Jaeger Ulrich, Schiefer Ana-Ir |
| Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial. Journal of cancer research and clinical oncology 2021 Oct . Broecker-Preuss Martina, Becher-Boveleth Nina, Müller Stefan P, Hüttmann Andreas, Hanoun Christine, Grafe Hong, Richter Julia, Klapper Wolfram, Rekowski Jan, Bockisch Andreas, Dührsen Ulri |
| Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma. Leukemia 2021 10 36 (3): 781-789. Newman Alexander M, Zaka Masood, Zhou Peixun, Blain Alex E, Erhorn Amy, Barnard Amy, Crossland Rachel E, Wilkinson Sarah, Enshaei Amir, De Zordi Julian, Harding Fiona, Taj Mary, Wood Katrina M, Televantou Despina, Turner Suzanne D, Burke G A Amos, Harrison Christine J, Bomken Simon, Bacon Chris M, Rand Vik |
| Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk. Cancer science 2022 9 113 (11): 3972-3979. Usui Yoshiaki, Iwasaki Yusuke, Matsuo Keitaro, Endo Mikiko, Kamatani Yoichiro, Hirata Makoto, Sugano Kokichi, Yoshida Teruhiko, Matsuda Koichi, Murakami Yoshinori, Maeda Yoshinobu, Nakagawa Hidewaki, Momozawa Yukihi |
| Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy. Leukemia 2022 9 36 (11): 2669-2677. Strati Paolo, Jallouk Andrew P, Sun Ryan, Choi Jaihee, Das Kaberi, Cherng Hua-Jay, Ahmed Sairah, Lee Hun J, Iyer Swaminathan P, Nair Ranjit, Nastoupil Loretta J, Steiner Raphael E, Huff Chad D, Yu Yao, Mistry Haleigh, Pulsifer Brittany, Noorani Mansoor, Saini Neeraj, Shpall Elizabeth J, Kebriaei Partow, Flowers Christopher R, Westin Jason R, Hildebrandt Michelle A T, Neelapu Sattva |
| Clinical significance of MYD88 non-L265P mutations in diffuse large B-cell lymphoma. Hematological oncology 2022 Sep . Xie Jialing, Shen Xia, Shi Qin, Yi Hongmei, Ouyang Binshen, Zhang Zhihan, Gu Yijin, Dong L |
| TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients. Cancer biomarkers : section A of Disease markers 2022 Sep . de Pádua Covas Lage Luís Alberto, Barreto Guilherme Carneiro, Culler Hebert Fabricio, Cavalcante Jéssica Billar, de Oliveira Alves Lucas Bassolli, Nardinelli Luciana, Bendit Israel, Zerbini Maria Cláudia Nogueira, Rocha Vanderson, Pereira Julia |
| Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma. American journal of hematology 2022 9 97 (12): 1538-1547. Lackraj Tracy, Ben Barouch Sharon, Medeiros Jessie J F, Pedersen Stephanie, Danesh Arnavaz, Bakhtiari Mehran, Hong Michael, Tong Kit, Joynt Jesse, Arruda Andrea, Minden Mark D, Kuruvilla John, Bhella Sita, Kukreti Vishal, Crump Michael, Prica Anca, Chen Christine, Deng Yangqing, Xu Wei, Pugh Trevor J, Keating Armand, Dick John E, Abelson Sagi, Kridel Robe |
| Association of ATG16L1 rs2241880 and TP53 rs1042522 with characteristics and course of diffuse large B-cell lymphoma. Pathology, research and practice 2022 Jul 237 154033. Živanovi? An?elina, Stamatovi? Dragana, Streli? Nataša, Magi? Zvonko, Tarabar Olivera, Miljanovi? Olivera, Mišovi? Miroslav, ?uki? Svetlana, Cikota-Aleksi? Boja |
| High Frequency of ASXL1 and IDH Mutations in Young Acute Myeloid Leukemia Egyptian Patients. Asian Pacific journal of cancer prevention : APJCP 2022 3 23 (3): 977-984. El Nahass Yasser H, Nader Heba A, Sabet Salwa, Nooh Hend A, Bassiony Heba, Kamel Mahmoud, Samra Mohamed A, Mahmoud Hossam K, El Metnawy Wafaa H, El Refaey Fatma |
| KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials. The Lancet. Haematology 2022 2 9 (2): e133-e142. Kaddu-Mulindwa Dominic, Altmann Bettina, Robrecht Sandra, Ziepert Marita, Regitz Evi, Tausch Eugen, Held Gerhard, Poeschel Viola, Lesan Vadim, Bittenbring Joerg Thomas, Thurner Lorenz, Pfreundschuh Michael, Christofyllakis Konstantinos, Truemper Lorenz, Loeffler Markus, Schmitz Norbert, Hoth Markus, Hallek Michael, Fischer Kirsten, Stilgenbauer Stephan, Bewarder Moritz, Rixecker Torben Milla |
| Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. Experimental hematology & oncology 2022 Oct 11 (1): 71. Li Shan-Shan, Zhai Xiao-Hui, Liu Hai-Ling, Liu Ting-Zhi, Cao Tai-Yuan, Chen Dong-Mei, Xiao Le-Xin, Gan Xiao-Qin, Cheng Ke, Hong Wan-Jia, Huang Yan, Lian Yi-Fan, Xiao Ji |
| Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 1 28 (5): 972-983. Xu-Monette Zijun Y, Wei Li, Fang Xiaosheng, Au Qingyan, Nunns Harry, Nagy Máté, Tzankov Alexandar, Zhu Feng, Visco Carlo, Bhagat Govind, Dybkaer Karen, Chiu April, Tam Wayne, Zu Youli, Hsi Eric D, Hagemeister Fredrick B, Sun Xiaoping, Han Xin, Go Heounjeong, Ponzoni Maurilio, Ferreri Andrés J M, Møller Michael B, Parsons Benjamin M, van Krieken J Han, Piris Miguel A, Winter Jane N, Li Yong, Xu Bing, Albitar Maher, You Hua, Young Ken |
| Polymorphism of VDR Gene and the Sensitivity of Human Leukemia and Lymphoma Cells to Active Forms of Vitamin D. Cancers 2022 1 14 (2): . Gleba Justyna Joanna, K?opotowska Dagmara, Banach Joanna, Turlej Eliza, Mielko Karolina Anna, G?bura Katarzyna, Bogunia-Kubik Katarzyna, Kutner Andrzej, Wietrzyk Joan |
| Outcomes of Gamma Knife Radiosurgery for Brain Metastases From Anaplastic Lymphoma Kinase Rearrangement-Positive and EGFR Mutation-Positive Non-Small Cell Lung Cancer. Cureus 2021 Dec 13 (12): e20398. Matsunaga Shigeo, Shuto Takas |
| Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation. Bone marrow transplantation 2022 1 57 (3): 460-465. Soerensen Johannes Frasez, Aggerholm Anni, Rosenberg Carina Agerbo, Bill Marie, Kerndrup Gitte Birk, Ebbesen Lene Hyldahl, Hansen Marcus Høy, Roug Anne Stidsholt, Ludvigsen Ma |
| Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
| Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan. Familial cancer 2022 Jul . Rashid Muhammad Usman, Muhammad Noor, Shehzad Umara, Khan Faiz Ali, Loya Asif, Hamann U |
| Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma. Annals of hematology 2023 9 . Osama Abd El Hameed Ebid, Lobna R Ezz El Arab, Amr S Saad, Mai Ezz El Din, Nermeen Mostafa, Menha Swell |
| Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy. Haematologica 2023 8 . Zhuoer Xie, Terra Lasho, Arushi Khurana, Alejandro Ferrer, Christy Finke, Abhishek A Mangaonkar, Stephen Ansell, Jenna Fernandez, Mithun Vinod Shah, Aref Al-Kali, Naseema Gangat, Jithma Abeykoon, Thomas E Witzig, Mrinal M Patna |
| Prevalence and significance of DDX41 gene variants in the general population. Blood 2023 7 . Sruthi Cheloor Kovilakam, Muxin Gu, William G Dunn, Ludovica Marando, Clea Barcena, Serena Nik-Zainal, Irina Mohorianu, Siddhartha Kar, Margarete Alice Fabre, Pedro M Quiros, George S Vassili |
| Inhibitory NKG2A and absent activating NKG2C NK cell responses are associated with the development of EBV lymphomas. Frontiers in immunology 2023 7 14 1183788. Hannes Vietzen, Philipp B Staber, Sarah M Berger, Philippe L Furlano, Laura M Kühner, Simone Lubowitzki, Alexander Pichler, Robert Strassl, Jan J Cornelissen, Elisabeth Puchhammer-Stöc |
| The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling. Cancers 2023 6 15 (12): . Katrin Merk-Ahmad, Julia Bein, Sonja Scharf, Hendrik Schäfer, Tobias Bexte, Evelyn Ullrich, Andreas G Loth, Nadine Flinner, Tina Senff, Olga Schneider, Martin-Leo Hansmann, Matthieu Piel, Björn Häupl, Thomas Oellerich, Emmanuel Donnadieu, Sylvia Hartma |
| Involvement of cutavirus in a subset of patients with cutaneous T-cell lymphoma with an unfavorable outcome. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2023 6 165 105523. Yumiko Hashida, Kimiko Nakajima, Tomonori Higuchi, Kozo Nakai, Masanori Daiba |
| Impact of HLA-mismatched unrelated transplantation in patients with adult T-cell leukemia/lymphoma. Bone marrow transplantation 2023 5 . Yoshitaka Inoue, Satoko Morishima, Koji Kato, Ayumu Ito, Nobuaki Nakano, Takuro Kuriyama, Toshiro Kawakita, Yasuo Mori, Youko Suehiro, Hidehiro Itonaga, Yasuhiko Miyazaki, Kazunori Imada, Shouhei Tomori, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Takahiro Fukuda, Makoto Yoshimitsu, |
| The outcome of ibrutinib-based regimens in relapsed/refractory central nervous system lymphoma and the potential impact of genomic variants. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2023 3 . Wang Shu, Zhu Yuqi, Qian Xiaohan, Ding Tianling, Yuan Yan, Li Yuan, Wu Hanfeng, Chen To |
| Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab. Annals of hematology 2023 1 102 (2): 393-402. Wang Fei, Lu Luo, Chen HuiJuan, Yue Yanhua, Sun Yanting, Yan Feng, He Bai, Lin Rongrong, Gu Weiyi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: